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ABSTRACT   Robot-assisted partial nephrectomy (RAPN) was introduced in our hospital for 
treating small renal cell carcinoma in May 2018; we examined treatment outcomes in 24 patients 
(25 kidneys) who had undergone this procedure till 2019. The median observation period was 
11 months (range, 1-17 months). The patients’ age range was 43-77 years (median, 68 years). 
Fourteen men and 10 women underwent the procedure. Their BMI was 17.9-39.7 (median, 24.1) 
kg/m2. In one patient, RAPN was performed twice at different times for treating bilateral renal 
cancer. The right kidney was affected in 12 cases and the left kidney in 13 cases. The clinical 
cancer stage was T1a in 20 cases and T1b in 5 cases. Tumor sizes were 0.9-6.2 cm (median, 
2.5 cm), and RENAL nephrometry scores were 4-10 (median, 7). The transperitoneal approach 
was used in 22 cases, and the retroperitoneal approach in 3. The operating durations were 147-
358 min (median, 225 min), console durations were 59-394 min (median, 152 min), and renal 
ischemia durations were 8-54 min (median, 21 min). Blood loss was 10-700 ml (median 10 ml), 
and none of the patients underwent blood transfusion. The histopathological analysis of the 
resected tumors revealed clear cell renal cell carcinoma in 20 cases, chromophobe renal cell 
carcinoma in 2 cases, and papillary renal cell carcinoma, angiomyolipoma, and leiomyoma in 1 
case each. All margins were negative. The postoperative hospital stay lengths were 5-14 days 
(median, 9 days). The postoperative deterioration in renal function was mild, and there were no 
severe complications. In the early stages after its introduction, RAPN was safely performed and 
allowed for the preservation of renal function. We plan to continue studying more cases going 
forward. 
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〈Regular Article〉
for urinary tract diseases have been established as 
minimally invasive means to obtaining positive 
INTRODUCTION
   In the field of urology, laparoscopic surgeries 
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was placed inside the renal pelvis to supply an 
indigo carmine-saline solution, and was fixed to the 
urethral catheter outside the body with silk thread. 
The patient was then placed in the lateral decubitus 
position. 
   The surgical procedure was performed by 
dissecting around the kidney outside Gerota’s 
fascia, identifying and dissecting the renal artery 
and vein, and then securing the renal artery with 
vascular tape. After dissecting the fat around the 
tumor, the tumor was identified using robot-assisted 
intraoperative ultrasonography, the resection line 
was marked, indigo carmine-saline drip was started 
from the ureteral catheter, and the renal artery 
was clamped with bulldog forceps. Sharp and 
blunt dissection of the tumor was then performed. 
Depending on the patient condition, hemostasis 
of the resection surface was performed with a 
combination of methods including soft coagulation, 
inner sutures of the base of the resection surface 
of the tumor, application or drops of a fibrinogen 
+ thrombin preparation, spraying a starch-derived 
absorbent local hemostatic material, and suturing of 
the renal parenchyma on the resection surface. After 
these procedures, the renal artery was unclamped, 
and after confirming the absence of bleeding, a 
drainage tube was inserted and the operation was 
finished. Two surgeons performed the procedures; 
however, the assistants and nurses were not fixed. 
The median follow-up period was 13 months (range, 
3-19 months).
RESULTS
   The age range of the patients was 43-77 years 
(median, 68 years); there were 14 men and 10 
women. In 1 patient, RAPN was performed twice 
for bilateral renal cancer at different times. The 
patients’ BMI range was 17.9-39.7 (median, 24.1) 
kg/m2. The right kidney was affected in 12 patients 
and the left kidney in 13. The clinical stage was T1a 
in 20 patients and T1b in 5. The tumor sizes were 
outcomes. A randomized controlled trial examining 
small renal tumors showed partial nephrectomy 
was similar to radical nephrectomy in terms of 
safety and cancer control１） and superior to radical 
nephrectomy in terms of preserving renal function２）, 
improving postoperative quality of life, reducing 
non-cancer-related mortality, and prolonging 
overall survival３，４）. Japanese guidelines have 
recommended that partial nephrectomy should be 
performed if it is technically feasible. Robot-assisted 
partial nephrectomy (RAPN) was first reported 
by Gettman et al. and is now performed in many 
facilities worldwide; positive therapeutic outcomes 
have been reported using this technique５）. In Japan, 
health insurance began covering this procedure from 
2016; therefore, the number of patients undergoing 
this procedure has rapidly increase since then. Our 
hospital introduced RAPN in May 2018. By the end 
of September 2019, it was performed on 24 patients 
(25 kidneys). In this study, we conducted a clinical 
investigation of the therapeutic outcomes after the 
introduction of RAPN. 
SUBJECTS AND METHODS
   This study was approved by the Ethics Committee 
of Kawasaki Medical School and Kawasaki Medical 
School Hospital (approval number 3,742). All 
authors have no conflict of interest which should 
be declared. Twenty-four patients (25 kidneys) 
diagnosed with renal cell carcinoma who underwent 
RAPN using the Davinci Xi surgical system 
from May 2018 to the end of September 2019 
were included. We retrospectively examined their 
characteristics, surgical and perioperative outcomes, 
pathological results, therapeutic outcomes, and 
postoperative renal function. 
   All  patients are evaluated 3-dimentional 
reconstruction images using preoperative computed 
tomography before surgery.
   Surgery was performed as follows. In the 
lithotomy position, the tip of a 5 Fr ureteral catheter 
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0.9-6.2 cm (median, 2.5 cm) and tumor location 
sites were 3 in the upper pole, 13 in the middle, and 
9 in the lower pole (Table 1). RENAL nephrometry 
scores were 4-10 (median, 7) and the details were 
shown in Table 2. Three patients had undergone 
appendicitis surgery, 1 had undergone robot-
assisted radical prostatectomy, and 1 had undergone 
contralateral RAPN. 
   The transperitoneal approach was used in 22 
patients and the retroperitoneal approach in 3. 
Pneumoperitoneum was performed at 8-15 mmHg. 
The number of ports was 6 with the transperitoneal 
approach and 4 with the retroperitoneal approach 
after  di lat ion of the retroperi toneal  space. 
Fig. 1 shows the port positions with the right 
transperitoneal approach.
   The operating durations were 147-358 min 
(median 225 min), console durations were 59-304 
min (median, 152 min), and renal ischemia durations 
were 8-54 min (median 21 min) except 1 case of 
no clamp of renal artery. Blood loss was 10-700 ml 
(median, 10 ml), and none of the patients underwent 
blood transfusion. No patients were transitioned 
to the open procedure. The postoperative hospital 
stays were 5-14 days (median, 9 days) (Table 3). 
Histopathological analysis revealed that the resected 
tumors was a clear cell renal cell carcinoma in 
20 patients, chromophobe renal cell carcinoma 
Table 1. Characteristics of patients  (24 cases, 25 kidneys)
Age (years) : 43 - 77 (median, 68)
Sex : Male 14, Female 10
BMI : 17.9 - 39.7 (median, 24.1)
Tumor side : Right 12, Left 13
Clinical T stage : T1a 20, T1b 5
Tumor location : upper pole 3, middle 13, lower pole 9
Table 2. RENAL nephrometry score (n=25)
4-10 pts (median 7 pts)
　4pts : 1, 5pts : 3, 6pts : 5, 7pts : 5, 8pts : 5, 9pts : 4, 10pts : 2
1pt 2pts 3pts
R 20 5 0
E 7 16 2
N 7 7 11
　(A : a 9, p 4, x 12)







Fig. 1. Port site of right transperitoneal RAPN
○ : camera port
● : port for Da Vinci
△ : port for assistant
▲ : Air seal port for assistant
RAPN: robot assisted laparoscopic partial nephrectomy
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in 2 patients, and papillary renal cell carcinoma, 
angiomyolipoma, and leiomyoma in 1 patient each. 
The pathological stage of renal cell carcinoma 
was pT1a in 17 cases, pT1b in 5 cases, and pT3a 
in 1 case. Regarding Fuhrman grade, grade 1 was 
3 cases, grade 2 was 10 cases, and grade 3 was 
10 cases. All margins were negative (Table 4). 
Although the observation periods were short, no 
recurrence or metastasis was observed. 
   Regarding postoperative renal function, the 
median eGFRs before and after 1, 3, 6, and 12 
months were 71.2, 68.5, 60.9, 62.7, and 66.4 ml/
min/1.73 m2, respectively (Fig. 2). These represent 
rates of decline of 3.8%, 14.5%, 11.5%, and 6.7%, 
respectively. 
   Regarding complications, intraoperative blood 
loss of ≥ 600 ml occurred in 2 patients; however, 
no severe Clavien-Dindo grade III or higher 
postoperative complications occurred. 
DISCUSSION
   Methods of performing partial nephrectomy for 
small renal cell carcinoma include open surgery, 
laparoscopic surgery, and RAPN. A comparison 
between open surgery and RAPN found the latter 
to be superior in terms of the amount of blood 
Table 3. Intra/perioperative Results (n=25)
Operation time (min) : 147 - 358 (median, 225)
Console time (min) : 59 - 304 (median, 152)
Blood loss (ml) : 10 - 700 (median, 10)
Transfusion : none
Open conversion : none
Postoperative hospital stay (days) : 5 - 14 (median, 9)
Complications: intraoperative bleeding more than 600ml 2 (8%)
Table 4. Pathological results (n=25)
Renal cell carcinoma
　Clear cell renal cell carcinoma 20（80%）
　Chromophobe renal cell carcinoma  2（8%）
　Papillary renal cell carcinoma  1（4%）
　pathological stage : pT1a 17, pT1b 5, pT3a 1
　Fuhrman grade : grade1 3, grade2 10, grade3 10



























Fig. 2. Changes in postoperative renal function
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loss, transfusion rate, length of hospital stay, re-
hospitalization rate, postoperative renal function, 
overall mortality, and recurrence rate, while a 
comparison between laparoscopic surgery and 
RAPN found the latter to be superior in terms of 
the intraoperative ischemia time, rate of transition 
to open surgery, intraoperative and postoperative 
complications, positive margin rate, postoperative 
renal function, and overall mortality６）. Considering 
such findings, the number of patients undergoing 
partial nephrectomy has been increasing since 
RAPN was introduced７）. Our hospital introduced 
the Davinci Xi surgical system in November 
2017 and started with robot-assisted radical 
prostatectomy. 
   At our hospital, patients with renal tumors up to 
7 cm are indicated to undergo RAPN, though the 
procedure can be difficult depending on the location 
of the tumor. Kutikov et al. proposed the RENAL 
nephrometry score as a method for scoring the 
risk of complications; this system was based on 
anatomical characteristics in preoperative images. 
Possible complications included the difficulty of 
partial nephrectomy, blood loss, and opening to the 
urinary tract. This score is now used worldwide, 
with 12 points indicating the highest degree of 
difficulty and 10 points a high degree of difficulty８）. 
The patients we experienced had scores of 4-10 
points, with a median score of 7 and 2 patients with 
scores of 10. In the future, we would like to create a 
more rigorous system for operating on such patients 
that considers the skill level of the surgeon and 
assistants. For contained tumors difficult to directly 
observe during surgery, we used 3-dimensional 
reconstruction images using preoperative computed 
tomography and robot-assisted intraoperative 
ultrasonography. All patients were resected safely 
with negative margins. There were no tumors in the 
renal hilum area that required dissection of renal 
blood vessels or the urinary tract, leaving this type 
of tumor as a topic for future study. 
   While either the transperitoneal or retroperitoneal 
approach can be used, there are no differences 
between them in terms of complications, transition 
to open surgery, warm ischemia time, blood loss, 
and positive margin rate９）. While either approach 
appears feasible, the location of the tumor in the 
kidney is important. The retroperitoneal approach 
is particularly useful for tumors in the posterior 
and lateral kidney10）. Initially, after RAPN was 
introduced, we used the transperitoneal approach 
in all patients; however, in 3 recent patients with 
tumors on the posterior kidney, we used the 
retroperitoneal approach. Although approaching the 
renal hilum is easy with this method, manipulations 
must be performed close to the camera, and the 
procedure can be difficult owing to reasons such as 
the small working space. Going forward, we plan to 
use the transperitoneal approach on anterior tumors, 
the retroperitoneal approach on posterior tumors, 
and leave the decision up to the surgeon for the best 
approach on lateral tumors. 
   The  so-ca l led  t r i fec ta－cancer  cont ro l , 
intraoperative and perioperative complications, and 
preservation of renal function－is being commonly 
used as an indicator of RAPN outcomes. Regarding 
cancer control, while we had no patients with 
recurrence or metastasis, the observation period was 
short and it was not worth evaluating. Therefore, we 
examined the complications and postoperative renal 
function. 
   We compared our outcomes to those of previous 
reports11，12）. Previous studies reported median 
operation durations of 118 and 140 min, which 
are shorter than the 225 min noted in our patients. 
However, our recent cases have shown durations 
been below 200 min, which indicates that the 
procedures are gradually getting shorter. Previous 
reports demonstrated blood loss to be 120 and 440 
ml. While the median amount in our patients was 
only 10 ml, we did experience blood loss of 700 
ml, indicating that we need to be careful about 
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indications and surgical manipulations. Warm 
ischemia time of the affected kidney may affect 
postoperative renal function, and renal function 
decreased when this lasted longer than 25 min13）. 
In previous reports, the median durations were 
20 and 27 min, while for our patients, it was 21 
min. The positive margin rate was 0%, both in 
previous reports and in our patients. Similarly, no 
patients were transitioned to open surgery and there 
were no Clavien-Dindo grade III or higher severe 
complications. Ramirez et al. performed a detailed 
examination of complications in 545 patients 
with T1a renal tumors who underwent RAPN14）. 
They reported bleeding and other intraoperative 
complications in 1.7% of patients and Clavien-
Dindo grade III or higher complications in 5.5%. 
Although our report is only on outcomes in a 
small number of cases for a short period of time, 
intraoperative bleeding of ≥ 600 ml, which normally 
requires blood transfusion, occurred in 2 patients 
(8%), which is slightly higher than that reported 
in previous studies and indicates that our surgical 
techniques need to improve. Postoperatively, no 
Clavien-Dindo grade III or higher complications 
occurred, which, for outcomes relatively soon after 
introducing RAPN, indicates that the procedure is 
being performed to an acceptable degree of safety. 
   Regarding postoperative renal function, there have 
been few reports on long-term outcomes, leaving 
the actual state of postoperative renal function 
unclear. Kim et al. reported long-term outcomes 
of renal function in 195 patients who underwent 
RAPN. They reported that eGFR levels were lowest 
at 3 months after surgery, after which they gradually 
increased, recovering to 95% of preoperative levels 
by 5 years postoperatively. New-onset stage III or 
IV chronic kidney disease (CKD) occurred after 
RAPN in 3.2% of patients15）. While there were 
only 8 patients with eGFR ≥ 60 ml/min/1.73 m2 
who were followed-up for at least 1 year in the 
present study, none developed CKD of stage III or 
higher, which, despite the short observation period, 
indicates that renal function was postoperatively 
maintained. Postoperative renal function is mainly 
determined by the warm renal ischemia time. 
Successful methods for minimizing the impact of 
ischemia on normal renal parenchyma include the 
early unclamping method, in which the renal artery 
is immediately unclamped after resecting the renal 
tumor and inner suturing of the base of the resection 
surface is done16）, and the selective clamp method, 
in which only the arteries that flow into the tumor 
are clamped17）. In the future, we plan to incorporate 
these methods to help preserve postoperative renal 
function and further improve outcomes. 
CONCLUSION
   We examined the outcomes of robot-assisted 
partial nephrectomy for renal cell carcinoma at 
our hospital. Although the operation times were 
somewhat long, the other results were similar to 
those reported previously, indicating the procedure 
was introduced safely. 
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